The Relationships Between Loss of Standard CD44 Expression and Lymph Node, Liver Metastasis in T3 Colorectal Carcinoma
- PMID: 19937401
- DOI: 10.1007/s12029-009-9100-0
The Relationships Between Loss of Standard CD44 Expression and Lymph Node, Liver Metastasis in T3 Colorectal Carcinoma
Abstract
Purpose: The aim of the present study was to evaluate the standard CD44 (CD44s) expression in colorectal cancer (CRC) with invasion to the subserosal layer (T3), its relationship with clinicopathological characteristics, and its potential metastatic significance.
Materials and methods: CD44s expression was measured on immunohistochemistry in tumors from 65 patients with primary colorectal carcinomas. CD44s expression was estimated at the deepest invaded area of the tumor in subserosal layer.
Results: CD44s was demonstrated in 35.4% (23/65). CD44s expression showed no significant relationship with the clinicopathological characteristics such as age, gender, tumor location, tumor size, and macroscopic/microscopic classification. However, the CD44s expression showed significantly adverse relationship with lymph node metastasis (p < 0.05) and liver metastasis (p < 0.01), respectively.
Conclusion: The loss of CD44s expression in cancer cells in the deepest invaded area is a good marker for predicting potential metastasis to lymph nodes and liver in T3 CRC.
Similar articles
-
The Prognostic Value of Cancer Stem Cell Markers (Notch1, ALDH1, and CD44) in Primary Colorectal Carcinoma.J Gastrointest Cancer. 2019 Dec;50(4):824-837. doi: 10.1007/s12029-018-0156-6. J Gastrointest Cancer. 2019. PMID: 30136202
-
Loss of standard type of CD44 expression in invaded area as a good indicator of lymph-node metastasis in colorectal carcinoma.Dis Colon Rectum. 2000 Sep;43(9):1250-4; discussion 1254-5. doi: 10.1007/BF02237430. Dis Colon Rectum. 2000. PMID: 11005492
-
Expression of CD44s in human colorectal cancer.Pathol Oncol Res. 2002;8(3):170-4. doi: 10.1007/BF03032390. Epub 2003 Jan 6. Pathol Oncol Res. 2002. PMID: 12515996
-
Expression and significance of CD44s, CD44v6, and nm23 mRNA in human cancer.World J Gastroenterol. 2005 Nov 14;11(42):6601-6. doi: 10.3748/wjg.v11.i42.6601. World J Gastroenterol. 2005. PMID: 16425351 Free PMC article.
-
Expression of proliferating cell nuclear antigen and CD44 variant exon 6 in primary tumors and corresponding lymph node metastases of colorectal carcinoma with Dukes' stage C or D.World J Gastroenterol. 2003 Jul;9(7):1482-6. doi: 10.3748/wjg.v9.i7.1482. World J Gastroenterol. 2003. PMID: 12854146 Free PMC article.
Cited by
-
The Prognostic and Clinical Value of CD44 in Colorectal Cancer: A Meta-Analysis.Front Oncol. 2019 Apr 30;9:309. doi: 10.3389/fonc.2019.00309. eCollection 2019. Front Oncol. 2019. PMID: 31114754 Free PMC article.
-
CD44 and p53 immunoexpression patterns in NF1 neoplasms - indicators of malignancy and infiltration.Int J Clin Exp Pathol. 2010 Jun 12;3(5):515-21. Int J Clin Exp Pathol. 2010. PMID: 20606732 Free PMC article.
-
Detection of Cancer Stem Cells in Colorectal Cancer: Histopathological and Immunohistochemical Study.Open Access Maced J Med Sci. 2016 Dec 15;4(4):543-547. doi: 10.3889/oamjms.2016.126. Epub 2016 Dec 7. Open Access Maced J Med Sci. 2016. PMID: 28028388 Free PMC article.
-
Loss of villin immunoexpression in colorectal carcinoma is associated with poor differentiation and survival.ISRN Gastroenterol. 2013 Sep 5;2013:679724. doi: 10.1155/2013/679724. eCollection 2013. ISRN Gastroenterol. 2013. PMID: 24083028 Free PMC article.
-
Extracellular matrix and its therapeutic potential for cancer treatment.Signal Transduct Target Ther. 2021 Apr 23;6(1):153. doi: 10.1038/s41392-021-00544-0. Signal Transduct Target Ther. 2021. PMID: 33888679 Free PMC article. Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous